Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase

  • Thomas A. Bonasera
  • , Giuseppina Ortu
  • , Yulia Rozen
  • , Roman Krais
  • , Nanette M.T. Freedman
  • , Roland Chisin
  • , Aviv Gazit
  • , Alexander Levitzki
  • , Eyal Mishani*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Abstract

As PET candidate tracers for EGFr-TK, five 4-(anilino)quinazoline derivatives, each fluorinated in the aniline moiety, were prepared. Each was tested in vitro for inhibition of EGFr autophosphorylation in A431 cell line. The leading compounds were then radiolabeled with 18F and cell binding experiments, biodistribution and PET studies in A431 tumor-bearing mice were performed. Metabolic studies were carried out in a mice control group. From our results, we concluded that while in vitro experiments indicates efficacy of 4-(anilino)quinazoline compounds, kinetic factors and rapid blood clearance make them unsuitable as tracers for nuclear medicine imaging of EGFr-TK.

Original languageEnglish
Pages (from-to)359-374
Number of pages16
JournalNuclear Medicine and Biology
Volume28
Issue number4
DOIs
StatePublished - 2001

Keywords

  • Biodistribution
  • EGFr
  • Fluorine-18
  • PET
  • Quinazoline
  • Tyrosine kinase

Fingerprint

Dive into the research topics of 'Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase'. Together they form a unique fingerprint.

Cite this